Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Study of Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease

NCT04912427 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04912427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Study of Isatuximab, Velcade, and Dexamethasone in Patients With Multiple Myeloma and Severe KIDNEY Disease
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
April 1, 2022
Completion date
January 26, 2024
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma